Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20200719048138N1
IRCT20200719048138N1
Completed
Phase 3

Evaluation of effect of treatment by fluoxetine on clinical prognosis in patients with Optic neuritis in comparison between drug and placebo groups.

Iran University of Medical Sciences0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
100
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Iranian patients
  • •Age over 18 years old
  • •Patients diagnosed with Optic neuritis

Exclusion Criteria

  • •History of multiple sclerosis
  • •cataract, glaucoma ( open or close angle ) congenital eye diseases such as coloboma and involvement with other disorders effecting the central visual field
  • •Patients with past medication history of using fluoxetine or other psychotherapeutics including antidepressants
  • •psychological disease
  • •medication history of arthemeter? astemizol, cisapride, eliglustat, goserelin, isocarboxazide, artemether, leuprolide, linezolid, lumefantrine, methylene blue, phenelzine, pimozide, procarbazine, selegiline, thioridazine, tranylcypromine
  • •Patients diagnosed with autoimmune and collagen vascular diseases
  • •Trauma or history of ophthalmologic surgeries
  • •Interval between involvement and interview more than 3 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Evaluation of effect of fluoxetine on the clinical prognosis in patients with anterior ischemic optic neuropathy (AION)
IRCT20181109041596N1Iran University of Medical Sciences100
Completed
Not Applicable
Effect of fluoxetine on clinical symptoms and echocardiographic findings in patients with mitral valve prolapse and generalized anxiety disorder.Condition 1: Generalized anxiety disorder. Condition 2: mitral valve prolapse.Generalized anxiety disorderMitral (valve) prolapse
IRCT2014102819721N1Sabzevar University of Medical Science60
Not yet recruiting
Not Applicable
The effectiveness of fluoxetine in the treatment of depressioMajor Depression.Mood disorder due to known physiological condition with major depressive-like episodeF06.32
IRCT20220706055386N1Esfahan University of Medical Sciences40
Completed
Not Applicable
The effect of Fluoxetine and Cognitive- Behavior Therapy on sexual functio
IRCT2013091014619N1Vice chancellor for research, Kashan University of Medical Sciences58
Recruiting
Phase 4
Evaluating The effect of fluoxetine on severity of depressive and anxiety symptoms in hemodialysis patientsCondition 1: Depressive symptoms in hemodialysis patients. Condition 2: Anxiety symptoms in hemodialysis patients.Major depressive disorder, single episodeGeneralized anxiety disorderF41.1
IRCT20220422054611N1Kerman University of Medical Sciences70